Joincare Pharma completes CNY 100m loan to Jiaozuo Jianfeng

Joincare Pharmaceutical Group Industry announced that it has completed the entrusted loan of CNY 100 million to its holding subsidiary, Jiaozuo Jianfeng Biotechnology Co., Ltd. The loan, initially approved on April 25, 2024, and detailed in previous announcements (临2024-038, 临2024-046, 临2024-102, 临2024-125, 临2025-009), carries a floating interest rate of LPR+65BP with a five-year term. As of June 24, 2025, CNY 80 million was allocated to project construction costs, while CNY 20 million was designated for working capital. The total entrusted loan amount represents 0.69% of Joincare's net assets attributable to shareholders of the parent company, based on the latest audited figures of CNY 1,453,471.96. The announcement confirms that there are no overdue entrusted loans.